Oral contraceptives hold top position as leading choice for women.
D000152:Acne Vulgaris; D000569:Americas; D003267:Contraception; D003268:Contraception Behavior; D003270:Contraceptive Agents; D003271:Contraceptive Agents, Female; D003276:Contraceptives, Oral; D003695:Delivery of Health Care; D003872:Dermatitis; D019049:Developed Countries; D004194:Disease; D005193:Family Planning Services; D006262:Health; D006282:Health Personnel; D006285:Health Planning; D017258:Medroxyprogesterone Acetate; D009656:North America; D010342:Patient Acceptance of Health Care; D010820:Physicians; D014481:United States
D003270:Contraceptive Agents; D003271:Contraceptive Agents, Female; D003276:Contraceptives, Oral; D017258:Medroxyprogesterone Acetate
Acceptors--women; Acne--prevention and control; Americas; Contraception; Contraceptive Agents; Contraceptive Agents, Female; Contraceptive Agents, Progestin; Contraceptive Methods; Contraceptive Methods Chosen; Contraceptive Usage; Delivery Of Health Care; Depo-provera; Dermatitis; Developed Countries; Diseases; Family Planning; Family Planning Programs; Health; Health Personnel; Medroxyprogesterone Acetate; North America; Northern America; Oral Contraceptives; Physicians; United States